Dianthus Therapeutics, Inc. (DNTH) vs Oruka Therapeutics, Inc. (ORKA)
A side-by-side comparison of Dianthus Therapeutics, Inc. and Oruka Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DNTH
Dianthus Therapeutics, Inc.
$85.40HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
ORKA
Oruka Therapeutics, Inc.
$80.18HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — DNTH vs ORKA
growth of $100 · dividends reinvested · last 8yDNTH -62.1% (-11.4%/yr)ORKA +19.0% (+2.2%/yr)ORKA compounded faster over this window
DNTH ORKA
DNTH vs ORKA: by the numbers
- •ORKA is the larger company ($4.84B vs $4.78B market cap).
- •Both run net losses; ORKA's is the smaller (0.00% vs -1570.85% net margin).
Metrics side by side
Valuation
| Metric | DNTH | ORKA |
|---|---|---|
| P/S ratio | 2508.82 | N/A |
| P/B ratio | 4.08 | 4.35 |
Profitability
| Metric | DNTH | ORKA |
|---|---|---|
| Gross margin | 96.01% | 0.00% |
| Operating margin | -8739.34% | 0.00% |
| Net margin | -1570.85% | 0.00% |
| ROE | -2.55% | -11.92% |
| ROIC | -18.48% | -13.88% |
Growth (annualized)
| Metric | DNTH | ORKA |
|---|---|---|
| Total return CAGR (5Y) | -5.50% | 32.76% |
Frequently asked
- How have DNTH and ORKA total returns compared?
- Over the past 5 years, DNTH delivered -5.50% and ORKA delivered 32.76% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.